HIV Drug Resistance in the ART Era in Kenya
Official title: HIV Drug Resistance in the New Antiretroviral Therapy Era in Kenya
Funded at Miriam Hospital · NIH-11415039 · Data updated 2026-11-12
A study looking at how HIV drug resistance emerges and changes as treatment options evolve in Kenya, with an eye toward improving care where monitoring is limited.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Miriam Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | September 12, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $497,796 |
| NIH project number | 5R01AI186632-03 |
| Project ID | NIH-11415039 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with HIV in Kenya and similar low-resource settings who are on or starting antiretroviral therapy.
✕Less likely to help
If monitoring resources remain severely limited or if local HIV subtypes differ greatly from study sites, direct benefits may be limited.
What this research studies
This project explores how HIV drug resistance develops in real-world settings, especially in resource-limited areas in Kenya, as newer antiretroviral drugs become standard. Researchers will examine patterns of resistance and how monitoring practices affect treatment outcomes. The goal is to understand challenges and identify opportunities to strengthen monitoring and treatment strategies for people living with HIV in similar settings.
Why it matters
Potential benefit: Findings could lead to better testing and treatment approaches for HIV, potentially reducing failures and improving long-term health for patients.
How similar studies have gone: Prior work has shown that resistance patterns can influence treatment effectiveness, but the new ART era presents unique challenges and opportunities for updated guidance.
Where this research is happening
-
Miriam Hospital
Providence, United States Active
Researchers
- Principal investigator: Kantor, Rami — Miriam Hospital
- Study coordinator: Kantor, Rami
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.